HomeMarket NewsThe Bumpy Road Ahead: Regulus Therapeutics Falls Short on Q4 2023 EPS

The Bumpy Road Ahead: Regulus Therapeutics Falls Short on Q4 2023 EPS

By Ron Finklestien
Current Market Analysis

Actionable Trade Ideas

always free

RGLS stock - RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q4 2023

Source: iQoncept / Shutterstock

Regulus Therapeutics (NASDAQ:RGLS) has just unveiled its performance for the final quarter of 2023.

  • Regulus Therapeutics posted a disappointing earnings per share of -40 cents, falling short of the forecasted EPS of -39 cents by analysts.
  • The company did not generate any revenue during the quarter.

InvestorPlace Earnings, powered by TradeSmith data, provides automated coverage of quarterly earnings. The feature highlights critical data like earnings per share, revenue figures, and comparisons against analyst predictions. These updates are crafted with precision, ensuring rapid access to important financial insights. For feedback or corrections, reach out to us at editor@investorplace.com.

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/rgls-stock-earnings-regulus-therapeutics-for-q4-of-2023/.

©2024 InvestorPlace Media, LLC

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.

Read Now

Related Articles

spot_img

WallStreet Waves

Comprehensive stock market news coverage across various asset classes, including stocks, bonds, commodities, cryptocurrencies, and more. We believe in offering a holistic perspective, allowing our readers to stay ahead of the stock market and capitalize on emerging opportunities in tech stocks, small caps, biotechs and more!

most Popular

trending right now

© 2024 All Rights reserved | Powered by WallStreet Waves